Delivery Order SPE2DB22D2218-SPE2DB25FR1WS

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of BELBUCA 600 MCG FILM 60S, a pharmaceutical product. The contract has a Ceiling Value of $1,270.37 and a completion date of May 3, 2024. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BELBUCA 900 MCG FILM 60S, a pharmaceutical product, with a ceiling value of $2,433.63 and a completion date of February 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BELBUCA 750 MCG FILM 60S, a pharmaceutical product, and has a ceiling value of $1,460.16. The contract is a firm fixed-price, delivery order contract with a period of performance that runs through January 8, 2025. The contract does not have a set-aside designation, indicating it was competitively awarded....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of BELBUCA 300 MCG FILM 60S, a pharmaceutical product, with a ceiling value of $1,009.20 and a completion date of January 28, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BELBUCA 750MCG FLM 60S medical products, with a total ceiling value of $1,460.16 and a period of performance through March 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,488.72 and an ultimate completion date of December 12, 2024. The award is for the delivery of BELBUCA 750 MCG FILM 60S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,404.98, is for the delivery of BELBUCA 600 MCG FILM 60S, a prescription medication. The contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.86 firm fixed-price contract is for the supply of BELBUCA 600 MCG FILM 60S, a prescription medication. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,117.48, is for the delivery of BELBUCA 450 MCG FILM 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 26, 2025. The award is not associated with a set-aside program and appears to be an open competition...
This federal contract award is for the delivery of BELBUCA 900 MCG FILM 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,682.69. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 29, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB25FR1WS
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BELBUCA 300 MCG FILM 60S, a medical product, with a ceiling value of $2,910.67 and a period of performance ending on January 17, 2025.

The contract is an Indefinite Delivery Contract (IDC) that serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, valued at $999,999,999 and running through November 2026, covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 4/18/25, 3:56 AM